Novartis.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
80% 
Page quality
68% 
Page structure
79% 
Link structure
25% 
Server
100% 
External factors
100% 
SEO Score
Response time
0.23 s
File size
207.10 kB
Words
1273
Media files
22
Number of links
349 internal / 11 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Novartis
The page title is too short. (76 pixels of 580 max pixel length) Optimize title
The page title is only one word.
There are no duplicate words in the title
Meta description
(Critically important)
Working together, we can reimagine medicine to improve and extend people’s lives.
The length of the meta description is perfect. (515 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.novartis.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en
Server location: United States of America
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
abstractWorking together, we can reimagine medicine to improve and extend people’s lives.
google-site-verificationMl04WfS7Ss3mQoi-HOUTHQazFh1Fl28fYjOLLtaJSLc
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langen
twitter:cardsummary_large_image
twitter:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
twitter:site@novartis
twitter:titleNovartis
twitter:site:id17226612
twitter:creator@novartis
twitter:creator:id17226612
twitter:urlhttps://www.novartis.com/home
twitter:imagehttps://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg
twitter:image:altNovartis logo
og:site_nameNovartis
og:typeWebsite
og:urlhttps://www.novartis.com/home
og:titleNovartis
og:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
og:imagehttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:secure_urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:altNovartis logo
x-dns-prefetch-controlon
x-ua-compatibleie=edge
charsetutf-8

Test up to 1.000 webpages of novartis.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 1273 words. That's ok.
15.1% of the text are stop words.
The page contains a listing, which indicates a good text layout.
13 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 13.19 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width, initial-scale=1, shrink-to-fit=no" is provided.
Bold and strong tags
(Somewhat important)
The amount of tags is very high (129). We recommend using a maximum of 25 tags for this page.
The following tag is repeated too often: international
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
/themes/custom/polaris/logo.svgNovartisHome
.../polaris/patterns/images/icon-search.svgOpen
...m/polaris/patterns/images/icon-close.svgClose
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...bed-kid-room-menu.jpg.webp?itok=KmIUz5U9Mother and daughter cuddling on a bed in a kids roomMother and daughter cuddling on a bed in a kids room
...ench-in-park-menu.jpg.webp?itok=5-8i5oYLAdult daughter talking to her senior parents on a bench in a parkAdult daughter talking to her senior parents on a bench in a park
...ood-pressure-menu.jpg.webp?itok=U5l7-GOFSmiling HCP taking senior patient's blood pressureSmiling HCP taking senior patient's blood pressure
...ientist-cambridge.jpg.webp?itok=_1WeOYMUA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...and-laughing-menu.jpg.webp?itok=fokSGWttGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...ptop-on-sofa-menu.jpg.webp?itok=ipyWZ-o1Business woman working on her laptop in a bright atmosphereBusiness woman working on her laptop in a bright atmosphere
...11/news-hero-menu.jpg.webp?itok=STu25KS9Overhead view of a meeting room with people in the foreground and screens in the backgroundOverhead view of a meeting room with people in the foreground and screens in the background
...-people-mega-menu.jpg.webp?itok=hwenfnKhTwo business peopleTwo business people
...ing-on-beach-menu.jpg.webp?itok=xtSMUGvgGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...laughing-on-beach.jpg.webp?itok=djN62APVGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...hess-and-laughing.jpg.webp?itok=qlEDLubbTwo men, seated indoors around a table, engaged in a conversation and playing chessTwo men, seated indoors around a table, engaged in a conversation and playing chess
...ientist-cambridge.jpg.webp?itok=XGxCz1arA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...ling-and-laughing.jpg.webp?itok=wVBQo2cDGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...024-media-content.jpg.webp?itok=qKxVa0EUQ3 2024Q3 2024
...ision-partnership.jpg.webp?itok=QjgsVT7vNovartis is an official partner of the Eurovision Song Contest 2025Novartis is an official partner of the Eurovision Song Contest 2025
...r-father-new-york.jpg.webp?itok=kGsAkDwDShanelle Gabriel spending time with her father in New YorkShanelle Gabriel spending time with her father in New York
...s-people-laughing.jpg.webp?itok=xyS0mD6NThree business people laughingThree business people laughing

Page structure

H1 heading
(Critically important)
Reimagining medicine, together
The H1 heading is perfect.
Headings
(Important)
The structure of headings is missing one or more levels. Do not skip heading levels.

Heading structure

Heading levelContent
H1 Reimagining medicine, together
H2 Novartis Financial Results – Q3 2024
H2 Official partner of the Eurovision Song Contest 2025
H2 Latest news
H2 Novartis in Society Integrated Report 2023
H2 Welcome to where we thrive together
H2 Resource links
H2 Novartis
H3 Discover our medicines
H3 Explore our science
H3 Learn about our impact
H3 Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
H3 Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation milestones; raises FY 2024 guidance
H3 Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial
H6 Working together
H6 Topics
H6 Explore
H6 Therapeutic areas
H6 Footer Bottom
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 11 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.novartis.com/Anchor Skip to main content
https://www.novartis.com/IMG-ALT Novartis
https://www.novartis.com/Anchor International
https://www.novartis.com/Anchor Americas
https://www.novartis.com/Anchor Asia Pacific
https://www.novartis.com/Anchor Europe
https://www.novartis.com/Anchor Middle East & Africa
https://www.novartis.com/Subdomain Global | English
https://www.novartisfoundation...External Subdomain Novartis Foundation | English
https://www.novartis.com/ar-es/Subdomain Argentina | Español
https://www.novartis.com/br-pt/Subdomain Brazil | Português
https://www.novartis.com/ca-en/Subdomain Canada | English
https://www.novartis.com/ca-fr/Subdomain Canada | Français
/candean-es/Subdomain Central America | Español
https://www.novartis.com/co-es/Subdomain Colombia | Español
https://www.novartis.com/mx-es/Subdomain Mexico | Español
https://www.novartis.com/us-en/Subdomain United States | English
https://www.novartis.com/au-en/Subdomain Australia | English
https://www.novartis.com/bd-en/Subdomain Bangladesh | English
https://www.novartis.com/hk-zh/Subdomain Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/in-en/Subdomain India | English
https://www.novartis.com/id-en/Subdomain Indonesia | English
https://www.novartis.com/jp-ja/Subdomain Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Korea | 한국어
https://www.novartis.com.cn/External Subdomain Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Malaysia | English
https://www.novartis.com/pk-en/Subdomain Pakistan | English
https://www.novartis.com/ph-en/Subdomain Philippines | English
https://www.novartis.com/sg-en/Subdomain Singapore | English
https://www.novartis.com/tw-zh/Subdomain Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Thailand | ภาษาไทย
https://www.novartis.com/at-de/Subdomain Austria | Deutsch
https://www.novartis.com/be-fr/Subdomain Belgium | Français
https://www.novartis.com/be-nl/Subdomain Belgium | Nederlands
https://www.novartis.com/bg-bg/Subdomain Bulgaria | Български
https://www.novartis.com/cz-cs/Subdomain Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Denmark | Dansk
https://www.novartis.com/ee-et/Subdomain Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain France | Français
https://www.novartis.com/de-de/Subdomain Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Greece | Ελληνικά
https://www.novartis.com/hu-hu/Subdomain Hungary | Magyar
https://www.novartis.com/ie-en/Subdomain Ireland | English
https://www.novartis.com/it-it/Subdomain Italy | Italiano
https://www.novartis.com/lv-lv/Subdomain Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Lithuania | Lithuanian
https://www.novartis.com/nl-nl/Subdomain Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Norway | Norsk
https://www.novartis.com/pl-pl/Subdomain Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Romania | Română
https://www.novartis.com/ru-ru/Subdomain Russia | Русский
https://www.novartis.com/rs-sr/Subdomain Serbia | Srpski
https://www.novartis.com/sk-sk/Subdomain Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Slovenia | English
https://www.novartis.com/es-es/Subdomain Spain | Español
https://www.novartis.com/se-se/Subdomain Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Switzerland | Français
https://www.novartis.com/tr-tr/Subdomain Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain United Kingdom | English
https://www.novartis.com/eg-en/Subdomain Egypt | English
https://www.novartis.com/il-he/Subdomain Israel | עברית
https://www.novartis.com/sa-ar/Subdomain Saudi Arabia | العربية
https://www.novartis.com/za-en/Subdomain South Africa | English
https://www.novartis.com/Anchor Text duplicate International
https://www.novartis.com/Anchor Text duplicate Americas
https://www.novartis.com/Anchor Text duplicate Asia Pacific
https://www.novartis.com/Anchor Text duplicate Europe
https://www.novartis.com/Anchor Text duplicate Middle East & Africa
https://www.novartis.com/ar-es/Subdomain Text duplicate Argentina | Español
https://www.novartis.com/au-en/Subdomain Text duplicate Australia | English
https://www.novartis.com/at-de/Subdomain Text duplicate Austria | Deutsch
https://www.novartis.com/bd-en/Subdomain Text duplicate Bangladesh | English
https://www.novartis.com/be-fr/Subdomain Text duplicate Belgium | Français
https://www.novartis.com/be-nl/Subdomain Text duplicate Belgium | Nederlands
https://www.novartis.com/br-pt/Subdomain Text duplicate Brazil | Português
https://www.novartis.com/bg-bg/Subdomain Text duplicate Bulgaria | Български
https://www.novartis.com/ca-en/Subdomain Text duplicate Canada | English
https://www.novartis.com/ca-fr/Subdomain Text duplicate Canada | Français
/candean-es/Subdomain Text duplicate Central America | Español
https://www.novartis.com/co-es/Subdomain Text duplicate Colombia | Español
https://www.novartis.com/cz-cs/Subdomain Text duplicate Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Text duplicate Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Text duplicate Denmark | Dansk
https://www.novartis.com/eg-en/Subdomain Text duplicate Egypt | English
https://www.novartis.com/ee-et/Subdomain Text duplicate Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Text duplicate Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain Text duplicate France | Français
https://www.novartis.com/de-de/Subdomain Text duplicate Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Text duplicate Greece | Ελληνικά
https://www.novartis.com/hk-zh/Subdomain Text duplicate Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/hu-hu/Subdomain Text duplicate Hungary | Magyar
https://www.novartis.com/in-en/Subdomain Text duplicate India | English
https://www.novartis.com/id-en/Subdomain Text duplicate Indonesia | English
https://www.novartis.com/ie-en/Subdomain Text duplicate Ireland | English
https://www.novartis.com/il-he/Subdomain Text duplicate Israel | עברית
https://www.novartis.com/it-it/Subdomain Text duplicate Italy | Italiano
https://www.novartis.com/jp-ja/Subdomain Text duplicate Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Text duplicate Korea | 한국어
https://www.novartis.com/lv-lv/Subdomain Text duplicate Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Text duplicate Lithuania | Lithuanian
https://www.novartis.com.cn/External Subdomain Text duplicate Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Text duplicate Malaysia | English
https://www.novartis.com/mx-es/Subdomain Text duplicate Mexico | Español
https://www.novartis.com/nl-nl/Subdomain Text duplicate Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Text duplicate Norway | Norsk
https://www.novartis.com/Subdomain Text duplicate Global | English
https://www.novartisfoundation...External Subdomain Text duplicate Novartis Foundation | English
https://www.novartis.com/pk-en/Subdomain Text duplicate Pakistan | English
https://www.novartis.com/ph-en/Subdomain Text duplicate Philippines | English
https://www.novartis.com/pl-pl/Subdomain Text duplicate Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Text duplicate Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Text duplicate Romania | Română
https://www.novartis.com/ru-ru/Subdomain Text duplicate Russia | Русский
https://www.novartis.com/sa-ar/Subdomain Text duplicate Saudi Arabia | العربية
https://www.novartis.com/rs-sr/Subdomain Text duplicate Serbia | Srpski
https://www.novartis.com/sg-en/Subdomain Text duplicate Singapore | English
https://www.novartis.com/sk-sk/Subdomain Text duplicate Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Text duplicate Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Text duplicate Slovenia | English
https://www.novartis.com/za-en/Subdomain Text duplicate South Africa | English
https://www.novartis.com/es-es/Subdomain Text duplicate Spain | Español
https://www.novartis.com/se-se/Subdomain Text duplicate Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Text duplicate Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Text duplicate Switzerland | Français
https://www.novartis.com/tw-zh/Subdomain Text duplicate Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Text duplicate Thailand | ภาษาไทย
https://www.novartis.com/tr-tr/Subdomain Text duplicate Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain Text duplicate United Kingdom | English
https://www.novartis.com/us-en/Subdomain Text duplicate United States | English
https://www.novartis.com/aboutAbout
A-TITLE About
/about/board-directorsBoard of Directors
A-TITLE Board of Directors
/about/board-directors/joerg-r...Joerg Reinhardt
A-TITLE Joerg Reinhardt
/about/board-directors/simon-m...Simon Moroney
A-TITLE Simon Moroney
/about/board-directors/nancy-c...Nancy C. Andrews
A-TITLE Nancy C. Andrews
/about/board-directors/ton-bue...Ton Buechner
A-TITLE Ton Buechner
/about/board-directors/patrice...Patrice Bula
A-TITLE Patrice Bula
/about/board-directors/elizabe...Elizabeth (Liz) Doherty
A-TITLE Elizabeth (Liz) Doherty
/about/board-directors/ana-de-...Ana de Pro Gonzalo
A-TITLE Ana de Pro Gonzalo
/about/board-directors/bridget...Bridgette Heller
A-TITLE Bridgette Heller
/about/board-directors/daniel-...Daniel Hochstrasser
A-TITLE Daniel Hochstrasser
/about/board-directors/frans-v...Frans van Houten
A-TITLE Frans van Houten
/about/board-directors/charles...Charles L. Sawyers
A-TITLE Charles L. Sawyers
/about/board-directors/william...William T. Winters
A-TITLE William T. Winters
/about/board-directors/john-d-...John D. Young
A-TITLE John D. Young
/about/board-directors/charlot...Charlotte Pamer-Wieser
A-TITLE Charlotte Pamer-Wieser
/about/executive-committeeExecutive Committee
A-TITLE Executive Committee
/about/executive-committee/vas...Vasant (Vas) Narasimhan
A-TITLE Vasant (Vas) Narasimhan
/about/executive-committee/shr...Shreeram Aradhye
A-TITLE Shreeram Aradhye
/about/executive-committee/vic...Victor Bulto
A-TITLE Victor Bulto
/about/executive-committee/aha...Aharon (Ronny) Gal
A-TITLE Aharon (Ronny) Gal
/about/executive-committee/kar...Karen L. Hale
A-TITLE Karen L. Hale
/about/executive-committee/pat...Patrick Horber
A-TITLE Patrick Horber
/about/executive-committee/har...Harry Kirsch
A-TITLE Harry Kirsch
/about/executive-committee/rob...Rob Kowalski
A-TITLE Rob Kowalski
/about/executive-committee/ste...Steffen Lang
A-TITLE Steffen Lang
/about/executive-committee/fio...Fiona Marshall
A-TITLE Fiona Marshall
/about/executive-committee/kla...Klaus Moosmayer
A-TITLE Klaus Moosmayer
/about/executive-committee/lut...Lutz Hegemann
A-TITLE Lutz Hegemann
/about/executive-committee/kee...Kees Roks
A-TITLE Kees Roks
/about/executive-committee/mic...Michelle Weese
A-TITLE Michelle Weese
/about/productsProducts
A-TITLE Products
/about/therapeutic-areasTherapeutic areas
A-TITLE Therapeutic areas
/about/therapeutic-areas/cardi...Cardiovascular, renal and metabolic
A-TITLE Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Immunology
A-TITLE Immunology
/about/therapeutic-areas/neuro...Neuroscience
A-TITLE Neuroscience
/about/therapeutic-areas/oncologyOncology
A-TITLE Oncology
/about/people-and-culturePeople and culture
A-TITLE People and culture
/about/diversity-equity-and-in...Diversity, equity and inclusion
A-TITLE Diversity, equity and inclusion
/about/diversity-equity-and-in...Equity
A-TITLE Equity
/about/diversity-equity-and-in...Inclusivity
A-TITLE Inclusivity
/about/diversity-equity-and-in...Parental leave
A-TITLE Parental leave
/about/diversity-equity-and-in...Society
A-TITLE Society
/about/novartis-gene-therapiesNovartis Gene Therapies
A-TITLE Novartis Gene Therapies
/about/manufacturingManufacturing
A-TITLE Manufacturing
/about/qualityQuality
A-TITLE Quality
/about/quality/audit-programAudit program
A-TITLE Audit program
/about/quality/novartis-qualit...Novartis quality management system (QMS)
A-TITLE Novartis quality management system (QMS)
/about/quality/product-and-pat...Product and patient safety training
A-TITLE Product and patient safety training
/about/quality/regulatory-insp...Regulatory inspections
A-TITLE Regulatory inspections
/about/quality/product-recallsProduct recalls
A-TITLE Product recalls
/about/quality/third-party-sup...Third-party suppliers
A-TITLE Third-party suppliers
/about/awards-and-recognitionAwards and recognition
A-TITLE Awards and recognition
/patients-and-caregiversPatients and caregivers
A-TITLE Patients and caregivers
/patients-and-caregivers/novar...Novartis commitment to patients and caregivers
A-TITLE Novartis commitment to patients and caregivers
https://www.novartis.com/diseasesDiseases
A-TITLE Diseases
/investors/reporting-and-trans...Patient organization funding
A-TITLE Patient organization funding
/news/stories/patient-perspect...Patients perspectives stories
A-TITLE Patients perspectives stories
/healthcare-professionalsHealthcare professionals
A-TITLE Healthcare professionals
/healthcare-professionals/medi...Medical congresses and events
A-TITLE Medical congresses and events
/healthcare-professionals/medi...ASCO Annual Meeting
A-TITLE ASCO Annual Meeting
/about/productsText duplicate Products
A-TITLE Products
/research-development/novartis...Novartis pipeline
A-TITLE Novartis pipeline
/healthcare-professionals/mana...Managed access programs
A-TITLE Managed access programs
/healthcare-professionals/mana...Zolgensma® Global Managed Access Program (gMAP)
A-TITLE Zolgensma® Global Managed Access Program (gMAP)
/healthcare-professionals/nova...Novartis external funding
A-TITLE Novartis external funding
/healthcare-professionals/heal...Healthcare professional resources by country
A-TITLE Healthcare professional resources by country
/healthcare-professionals/inve...Investigator-initiated trials / studies
A-TITLE Investigator-initiated trials / studies
/healthcare-professionals/nova...Novartis medical information
A-TITLE Novartis medical information
/healthcare-professionals/nova...Submit medical enquiry
A-TITLE Submit medical enquiry
/research-and-developmentResearch and development
A-TITLE Research and development
/research-and-development/tech...Technology platforms
A-TITLE Technology platforms
/research-and-development/rese...Research disease areas
A-TITLE Research disease areas
/research-and-development/rese...Cardiovascular and metabolic disease research at Novartis
A-TITLE Cardiovascular and metabolic disease research at Novartis
/research-and-development/rese...DAx: exploratory disease research at Novartis
A-TITLE DAx: exploratory disease research at Novartis
/research-and-development/rese...Global Health disease area research at Novartis
A-TITLE Global Health disease area research at Novartis
/research-and-development/rese...Immunology disease research at Novartis
A-TITLE Immunology disease research at Novartis
/research-and-development/rese...Neuroscience research at Novartis
A-TITLE Neuroscience research at Novartis
/research-and-development/rese...Oncology research at Novartis
A-TITLE Oncology research at Novartis
/research-and-development/rese...Ophthalmology research at Novartis
A-TITLE Ophthalmology research at Novartis
/research-development/novartis...Text duplicate Novartis pipeline
A-TITLE Novartis pipeline
/research-and-development/rese...Research collaborations
A-TITLE Research collaborations
/research-and-development/coll...Collaborations
A-TITLE Collaborations
https://www.novartis.com/esgESG
A-TITLE ESG
/esg/accessAccess
A-TITLE Access
/esg/access/creating-sustainab...Creating sustainable business models
A-TITLE Creating sustainable business models
/esg/access/value-based-pricingValue-based pricing
A-TITLE Value-based pricing
/esg/access/sub-saharan-africaSub-Saharan Africa
A-TITLE Sub-Saharan Africa
/esg/access/donationsDonations
A-TITLE Donations
/esg/access/novartis-access-pr...Novartis access principles
A-TITLE Novartis access principles
/esg/access/novartis-oncology-...Novartis oncology access
A-TITLE Novartis oncology access
/esg/access/patents-and-licensingPatents and licensing
A-TITLE Patents and licensing
/esg/environmental-sustainabilityEnvironmental sustainability
A-TITLE Environmental sustainability
/esg/environmental-sustainabil...Climate
A-TITLE Climate
/esg/environmental-sustainabil...Waste
A-TITLE Waste
/esg/environmental-sustainabil...Water
A-TITLE Water
/esg/ethics-risk-and-complianceEthics, risk and compliance
A-TITLE Ethics, risk and compliance
/esg/ethics-risk-and-complianc...Ethical behavior
A-TITLE Ethical behavior
/esg/ethics-risk-and-complianc...Compliance
A-TITLE Compliance
/esg/ethics-risk-and-complianc...Human rights
A-TITLE Human rights
/esg/ethics-risk-and-complianc...Learning and engagement
A-TITLE Learning and engagement
/esg/ethics-risk-and-complianc...Integrated risk assurance
A-TITLE Integrated risk assurance
/esg/global-healthGlobal health
A-TITLE Global health
/esg/global-health/pandemic-pr...Pandemic preparedness
A-TITLE Pandemic preparedness
/esg/global-health/avoidable-b...Avoidable blindness
A-TITLE Avoidable blindness
/diseases/chagas-diseaseChagas disease
A-TITLE Chagas disease
/diseases/leprosyLeprosy
A-TITLE Leprosy
/diseases/malariaMalaria
A-TITLE Malaria
/diseases/sickle-cell-diseaseSickle cell disease (SCD)
A-TITLE Sickle cell disease (SCD)
https://www.novartisfoundation...New window External Subdomain Novartis Foundation
A-TITLE Novartis Foundation
/about/diversity-equity-and-in...Text duplicate Diversity, equity and inclusion
A-TITLE Diversity, equity and inclusion
/esg/indexESG index
A-TITLE ESG index
/investors/reporting-and-trans...Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Novartis in Society Integrated Report
A-TITLE Novartis in Society Integrated Report
/investors/reporting-and-trans...ESG rating performance
A-TITLE ESG rating performance
/investors/reporting-and-trans...Targets
A-TITLE Targets
/investors/reporting-and-trans...Text duplicate Patient organization funding
A-TITLE Patient organization funding
/investors/reporting-and-trans...Payments to healthcare professionals
A-TITLE Payments to healthcare professionals
/investors/reporting-and-trans...Public policy
A-TITLE Public policy
/investors/reporting-and-trans...A living wage
A-TITLE A living wage
/investors/reporting-and-trans...A safe workplace
A-TITLE A safe workplace
/investors/reporting-and-trans...Animal research
A-TITLE Animal research
/investorsInvestors
A-TITLE Investors
/investors/event-calendarEvent calendar
A-TITLE Event calendar
/investors/financial-dataFinancial data
A-TITLE Financial data
/investors/financial-data/annu...Novartis annual results
A-TITLE Novartis annual results
/investors/financial-data/quar...Novartis quarterly results
A-TITLE Novartis quarterly results
/investors/financial-data/sec-...Novartis SEC filings
A-TITLE Novartis SEC filings
/investors/financial-data/prod...Product sales
A-TITLE Product sales
/investors/financial-data/fixe...Fixed-income securities
A-TITLE Fixed-income securities
/investors/financial-data/expe...Expected currency impact
A-TITLE Expected currency impact
/investors/share-data-analysisShare data and analysis
A-TITLE Share data and analysis
/investors/share-data-and-anal...Share monitor
A-TITLE Share monitor
/investors/share-data-and-anal...Dividend information
A-TITLE Dividend information
/investors/share-data-and-anal...Share ownership
A-TITLE Share ownership
/investors/share-data-analysis...Share overview
A-TITLE Share overview
/investors/share-data-and-anal...Return on investment calculator
A-TITLE Return on investment calculator
/investors/shareholder-informa...Shareholder information
A-TITLE Shareholder information
/investors/shareholder-informa...General Meetings
A-TITLE General Meetings
/investors/shareholder-informa...American Depositary Receipts (ADR)
A-TITLE American Depositary Receipts (ADR)
/investors/shareholder-informa...Share buyback
A-TITLE Share buyback
/investors/shareholder-informa...Frequently asked questions
A-TITLE Frequently asked questions
/investors/company-overviewCompany overview
A-TITLE Company overview
/investors/company-overview/co...Corporate governance
A-TITLE Corporate governance
/investors/reporting-and-trans...Text duplicate Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Text duplicate Novartis in Society Integrated Report
A-TITLE Novartis in Society Integrated Report
/investors/reporting-and-trans...Reporting archive
A-TITLE Reporting archive
/investors/reporting-and-trans...Text duplicate ESG rating performance
A-TITLE ESG rating performance
/news/stay-up-to-datePublications order form
A-TITLE Publications order form
https://www.novartis.com/esgText duplicate ESG
A-TITLE ESG
https://www.novartis.com/newsNews
A-TITLE News
/news/news-archiveNews archive
A-TITLE News archive
/news/media-libraryMedia library
A-TITLE Media library
https://www.novartis.com/storiesStories
A-TITLE Stories
/news/stay-up-to-dateSubscribe
A-TITLE Subscribe
/news/eventsEvents
A-TITLE Events
https://www.novartis.com/careersCareers
A-TITLE Careers
/careers/career-searchCareer search
A-TITLE Career search
/careers/our-business-functionsOur business functions
A-TITLE Our business functions
/careers/our-business-function...Careers in research and development
A-TITLE Careers in research and development
/careers/our-business-function...Careers in operations
A-TITLE Careers in operations
/careers/our-business-function...Careers in commercial and sales
A-TITLE Careers in commercial and sales
/careers/our-business-function...Careers in global functions
A-TITLE Careers in global functions
/careers/why-novartisWhy Novartis
A-TITLE Why Novartis
/careers/career-hubCareer hub
A-TITLE Career hub
https://novartis.willhire.co/New window External Subdomain Temporary contracts
A-TITLE Temporary contracts
/careers/early-careersEarly careers
A-TITLE Early careers
/careers/early-careers/graduatesGraduates
A-TITLE Graduates
/careers/early-careers/studentsStudents
A-TITLE Students
/careers/early-careers/us-biom...US Biomedical Research internship programs
A-TITLE US Biomedical Research internship programs
/careers/early-careers/communi...Community exploration and learning lab (CELL)
A-TITLE Community exploration and learning lab (CELL)
/clinicaltrialsClinical trials
A-TITLE Clinical trials
/partneringPartnering
A-TITLE Partnering
/supplier-portalSupplier portal
A-TITLE Supplier portal
https://www.novartis.com/reportNew window Report side effects
A-TITLE Report side effects
https://www.novartis.com/contactsContacts
A-TITLE Contacts
/about/therapeutic-areasDiscover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
IMG-ALT Two men, seated indoors around a table, engaged in a conversation and playing chess
/research-and-developmentExplore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
IMG-ALT A female research scientist in a lab looking at a sample
/news/events/novartis-financia...Learn more
A-TITLE Learn more
/news/official-partner-eurovis...Text duplicate Learn more
A-TITLE Learn more
/news/media-releases/novartis-...Oct 29, 2024 Media Release Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
/news/media-releases/novartis-...Oct 29, 2024 Media Release Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation milesto...
/news/media-releases/novartis-...Oct 27, 2024 Media Release Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial
/news/news-archiveAll news
A-TITLE All news
/investors/reporting-and-trans...View the online summary
A-TITLE View the online summary
https://www.novartis.com/careersWelcome to where we thrive together
A-TITLE Welcome to where we thrive together
https://www.novartis.com/careersJoin us
A-TITLE Join us
https://www.novartis.com/aboutAbout Novartis
A-TITLE About Novartis
/healthcare-professionalsText duplicate Healthcare professionals
A-TITLE Healthcare professionals
/patients-and-caregiversText duplicate Patients and caregivers
A-TITLE Patients and caregivers
/research-development/novartis...Pipeline
A-TITLE Pipeline
/about/productsText duplicate Products
A-TITLE Products
/patients-and-caregiversText duplicate Patients and caregivers
/healthcare-professionalsText duplicate Healthcare professionals
/research-and-developmentResearchers
https://www.novartis.com/careersJob seekers
https://www.novartis.com/newsJournalists
/investorsText duplicate Investors
/news/events/novartis-financia...Q3 2024
/esg/accessText duplicate Access
/about/diversity-equity-and-in...Diversity
https://www.novartis.com/esgText duplicate ESG
/esg/ethics-risk-and-complianc...SpeakUp
/research-development/novartis...Text duplicate Pipeline
/about/productsText duplicate Products
/clinicaltrialsText duplicate Clinical trials
/partneringText duplicate Partnering
https://www.novartis.com/storiesText duplicate Stories
/about/therapeutic-areas/cardi...Text duplicate Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Text duplicate Immunology
/about/therapeutic-areas/neuro...Text duplicate Neuroscience
/about/therapeutic-areas/oncologyText duplicate Oncology
https://www.linkedin.com/compa...New window External Subdomain A-TITLE LinkedIn
https://www.facebook.com/novartisNew window External Subdomain A-TITLE Facebook
https://x.com/novartisNew window External A-TITLE X formerly known as Twitter
https://www.instagram.com/nova...New window External Subdomain A-TITLE Instagram
https://www.youtube.com/user/n...New window External Subdomain A-TITLE Youtube
/terms-useTerms of use
https://www.novartis.com/privacyPrivacy
https://www.novartis.com/Anchor Cookie settings
https://www.novartis.com/contactsText duplicate Contacts
/about/locationsLocations
/sitemap.xmlSite map
/open-sourceOpen source
/accessibilityWeb accessibility
/novartis-directoryNovartis Site Directory
A-TITLE Novartis Site Directory

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.novartis.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is excellent with 0.23 seconds.
The file size of the HTML document is fine (207 kB).

HTTP Response Header

NameValue
dateSun, 10 Nov 2024 19:17:32 GMT
content-typetext/html; charset=UTF-8
cache-controlmax-age=60, public, s-maxage=2628000, stale-if-error=180, stale-while-revalidate=180
content-languageen
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
expiresSun, 19 Nov 1978 05:00:00 GMT
last-modifiedSun, 10 Nov 2024 00:00:37 GMT
varyCookie,Accept-Encoding
content-security-policy-report-onlyscript-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob:; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com; frame-ancestors self; report-uri /report-csp-violation
x-xss-protection1; mode=block
strict-transport-securitymax-age=31536000; includeSubDomains
x-request-idv-d0f260d2-9ef6-11ef-82ff-97dc6b406443
x-ah-environmentprod
age1030
viavarnish
x-cacheHIT
x-cache-hits1040
cf-cache-statusHIT
server-timingcfCacheStatus;desc="HIT"
servercloudflare
cf-ray8e08621bdee86949-FRA
content-encodinggzip
statuscode200
http_versionHTTP/2

External factors

This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 15,636 referring domains.
This page has 1,343,029 backlinks.
This page has backlinks from 10,876 different ip addresses.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files

Disallow: /web.config
# Paths (clean URLs)

Disallow: /comment/reply/
Disallow: /filter/tips

Disallow: /search/




# Paths (no clean URLs)

Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips

Disallow: /index.php/search/




Disallow: /*printable
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /*/spc/*FAQ*
Disallow: /*/spc/*RMP*
Disallow: /*FAQ*
Disallow: /*RMP*

User-agent: GPTBot
Crawl-delay: 2

User-agent: bingbot
Crawl-delay: 2

User-agent: GoogleOther
Crawl-delay: 2

Similar sites

Search preview

www.novartis.com
Novartis
Working together, we can reimagine medicine to improve and extend people’s lives.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Novartis72%Check
medicine66%Check
reimagine medicine58%Check
Novartis Society56%Check
Working54%Check
Novartis Foundation54%Check
People52%Check
extend people49%Check
Q3 202448%Check
Novartis Society Integrated47%Check
Show more keywords and terms

Test up to 1.000 webpages of novartis.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions